University Hospital, Basel, Switzerland
Clinical trials sponsored by University Hospital, Basel, Switzerland, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Sugar showdown: which sweetener wreaks havoc on your gut? Results expected Sep 2026 (estimated)
- Diabetes drug shows promise for dangerous low sodium condition Results expected Sep 2026 (estimated)
- Which High-Tech camera is better at spotting skin cancer? Results expected Sep 2026 (estimated)
- Can the 'love hormone' calm anxiety in diabetes insipidus? Results expected Oct 2026 (estimated)
- Gastric bypass limb lengths: a key to better metabolic outcomes? Results expected Oct 2026 (estimated)
-
Can a single stitch beat a double closure for TAVI patients?
Disease control Not yet recruitingThis trial compares two methods for closing the main artery in the leg after a TAVI procedure, which replaces a heart valve without open surgery. Half of the participants will have the artery closed with a single suture device, while the other half will receive a hybrid approach …
Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can adding a second ablation target stop atrial fibrillation from coming back?
Disease control Not yet recruitingThis study is testing two ways to perform a repeat ablation procedure in people with atrial fibrillation (an irregular heartbeat) that has returned after a first treatment. Both approaches use pulsed-field ablation to isolate the pulmonary veins, but one also adds ablation of the…
Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Blue dye could prevent wound problems after groin surgery
Disease control Not yet recruitingThis pilot study tests a simple method to reduce wound complications after groin vascular surgery. Surgeons will inject a blue dye into the skin around the surgical wound to make any lymphatic leaks visible, then repair them immediately. The study will enroll 60 adults and track …
Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New CAR t therapy targets two proteins to fight blood cancers
Disease control Not yet recruitingThis early-phase trial tests a new type of CAR T cell therapy that targets two proteins (CD19 and CD20) on B cell cancer cells. It is for adults with B cell leukemia or lymphoma who have run out of standard options, including commercial CAR T cells. The main goal is to check safe…
Phase 1 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can a common sedative stop ICU delirium in heavy drinkers?
Prevention Not yet recruitingThis study tests whether giving lorazepam, a sedative, can prevent delirium in intensive care patients who are at high risk due to heavy alcohol use. Researchers will use a blood test (Anttila-Index) to identify these patients. The trial involves 260 adults admitted to the ICU, w…
Phase 4 • Sponsor: University Hospital, Basel, Switzerland • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
Could common painkillers boost opioid effectiveness for cancer patients?
Symptom relief Not yet recruitingThis trial investigates whether adding the non-opioid drugs metamizole (dipyrone) or ibuprofen to standard opioid therapy provides better pain relief for people with cancer-related pain. About 318 adults with advanced cancer and moderate to severe pain will receive either metamiz…
Phase 3 • Sponsor: University Hospital, Basel, Switzerland • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Which High-Tech camera is better at spotting skin cancer?
Knowledge-focused Not yet recruitingThis study compares two total body photography systems used to screen for melanoma, a serious skin cancer. One system, Deviskan, takes automated images with non-contact dermoscopy, while the other, Vectra WB360, uses 3D photography with manual dermoscopy. Researchers will ask 60 …
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Could a simple Chest-and-Arm patch replace bulky heart monitors?
Knowledge-focused Not yet recruitingThis study tests a new wearable system called M2VS that measures heart activity (ECG) and blood pressure continuously for 24 hours. Researchers want to see if it works as well as standard monitors like Holter ECG and ambulatory blood pressure monitors. The study involves 20 adult…
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Could a 3-Step hand wash beat the standard 6-Step?
Knowledge-focused Not yet recruitingThis study compares a quick 3-step hand hygiene technique to the standard 6-step method recommended by the World Health Organization. Researchers want to see if the simpler method leads to better compliance among healthcare workers and still keeps hands clean. The trial will invo…
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Ecstasy drug used to probe social brain in autism
Knowledge-focused Not yet recruitingThis study gives 40 adults—half with autism, half without—a single dose of MDMA (the active ingredient in ecstasy) or a placebo to see how it changes oxytocin levels in the blood. Oxytocin is often called the 'love hormone' and helps with social bonding. The goal is not to treat …
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Can a smart patch replace a pill for temperature monitoring?
Knowledge-focused Not yet recruitingThis small study with 12 adults checks if wearable temperature sensors can collect reliable data when compared to an ingestible capsule that measures core body temperature. Participants wear the sensors and swallow the capsule for about 48 hours. The goal is to see if the process…
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC